Non-GLP Toxicology
Services
Obtain high-quality, dependable toxicology data early in the drug development process.
Proficiencies
Explora BioLabs knows that high-quality exploratory non-GLP toxicology data is critical to the early stages of drug development. Our scientists support discovery and investigational non-GLP toxicology.
- Non-GLP safety assessment of small molecules and biologics
- Maximum-tolerated dose (MTD)
- Dose-range finding (DRF)
- Acute toxicology
- Sub-chronic toxicology (repeated dose)
- Established study protocols
- Common dose routes (IP, IV, IM, SC, PO)
- Complex dosing routes
- Single or repeat dose administration
- Continuous infusion
- Tissue collection with or without perfusion to determine biodistribution
- Animal species: mouse, rat
- Stringent IACUC oversight
Assessments
- In-life clinical observations
- Sample collection for clinical chemistry, hematology, urinalysis, etc.
- Comprehensive necropsy
- Blood sampling
- Histopathology
Extend Your Capabilities
Explora has nurtured strong working relationships with numerous reputable bioanalytical companies for efficiently processing and analyzing samples from our non-GLP toxicology studies. We can manage entire studies from drug to report, promising rapid turnaround times and high-quality results.
Learn More
Download our non-GLP Toxicology brochure today, or contact us for more information.
Request a Study Quote
To request a study quote, please fill out our form and a specialist will get back to you shortly.
